Flagellin, the ligand of Toll like receptor 5, is the major subunit of bacterial flagella. Flagellin stimulates various cells to release chemokines. Monocyte chemoattractant protein-1 (MCP-1) is a member of the CC chemokine family that is involved in monocyte infiltration in inflammatory diseases. It has been reported that serum MCP-1 levels increase proportionally with the severity of periodontal disease. Inflammatory mediators induce MCP-1 production in various cells, including osteoblasts. However, it remains unclear whether MCP-1 is released from osteoblasts in response to flagellin. In the present study, we investigated the effects of flagellin on the expression of MCP-1 in the mouse osteoblastic cell line, MC3T3-E1 (E1) cells. Flagellin markedly increased MCP-1 mRNA level in a dose-dependent manner. The effect of flagellin on MCP-1 mRNA expression in E1 cells was transient, with a peak at 1 h. Concomitant with MCP-1 mRNA expression, MCP-1 protein levels were clearly elevated at 3 h after flagellin exposure. In addition, we revealed that JNK and MEK-ERK1/2 are involved in flagellin-induced MCP-1 expression in E1 cells. These results indicated that bacterial flagellin may play an important role in the progression of periodontitis. Results of further studies will provide more clues to the prevention of periodontal diseases.
Periodontitis is a chronic polymicrobial infection that leads to inflammation of gingival tissues, and the destruction of the periodontal ligament and adjacent supporting alveolar bone. It is the one of the most significant causes of tooth loss in adults (22, 23) . Specific gram-negative anaerobic bacterial species are recognized as etiologic agents in periodontitis. Periodontitis is initiated by changes in the bacterial species composition of dental plaque, and the subsequent alteration of the host immune response (27) . It has been reported that various cytokines and chemokines are produced by cells in inflamed gingival tissues (4, 5) . Treponema denticola is a component of the 'red complex' of bacteria (T. denticola, Tannerella forsythia, and Porphyromonas gingivalis), and plays a major role in the development and progression of periodontal disease (2, 26, 28, 29) . In the previous study, T. denticola has been shown to cause alveolar bone loss in murine models of disease (12) . T. denticola contains flagellin, which is the major subunit of periplasmic flagella (17) . Flagellin is a ligand of toll like receptor (TLR) 5 (8) . It has been reported that flagellin can stimulate various cells to release chemokines (18, 25) . Chemokines are low molecular weight, inducible proinflammatory cytokines that are involved in reg-Tra Ace (Toyobo, Osaka, Japan) and was subjected to PCR amplification with AmpliTaq Gold DNA polymerase (Roche Molecular Systems, Braunchburg, NJ). Sequences of the TLR5 primers were: 5'-GAA AGT AAG AGG TAC AGA AAG CTG-3' and 5'-TAT AGT TGT GGG GAA GAA AGA AGG-3'. Amplification was conducted for 35 cycles. The annealing temperature of TLR5 was 55°C. After amplification, the synthesized PCR product was separated by electrophoresis on a 1% agarose gel and visualized by ethidium bromide staining.
Real-time RT-PCR. Reverse transcription to cDNA was performed directly from cultured E1 cell lysate using the TaqMan ® Gene Expression Cells-to-Ct Kit (Ambion Inc., Austin, TX), following manufacturer's instructions. Briefly, E1 cells were lysed with Lysis Solution, and RNA was released into this solution. Cell lysates were reverse transcribed to synthesize cDNA using the RT Enzyme Mix and RT Buffer. Quantitative real-time RT-PCR was performed using the TaqMan ® Gene Expression master mix and the TaqMan ® Gene Expression assays, performed on an ABI 7300 real-time PCR system (Applied Biosystems). PCR conditions were 50°C for 2 min, 95°C for 10 min; then 40 cycles of 95°C for 15 s and 60°C for 1 min. The TaqMan ® Gene Expression assays used were as follows: MCP-1; Mm00441242_m1, β-actin; 4352341E. Relative mRNA levels were determined by comparing the PCR cycle (Ct) for the MCP-1 and β-actin (ΔCt). The ΔCt values for flagellin-treated and control groups (ΔΔCt) were described previously (14) .
ELISA. Quantification of mouse MCP-1 in the culture supernatants was performed using a commercially available ELISA kit (RayBiotech, Inc., Norcross, GA), according to the manufacturer's instructions.
Statistical analysis. The mean ± standard error (S.E.) was determined for each treatment group in a given experiment, and all experiments were performed at least three times. Treatment groups were compared with the appropriate control group, and statistical significance was determined using the paired t-test or the Dunnett's test.
RESULTS

MCP-1 mRNA expression by flagellin-stimulated mouse osteoblastic E1 cells
Flagellin is a ligand for TLR5. Therefore, we first examined whether E1 cells express the TLR5 mRNA.
ulating the chemotaxis and activation of specific leukocytes to sites of inflammation. Chemokines have been divided into four subgroups (CC, CXC, C, and CX 3 C), based on the positioning of amino acids relative to the first two conserved cysteine residues (19, 32) . Monocyte chemoattractant protein-1 (MCP-1; CCL2) is a member of the CC chemokine family that is involved in monocyte infiltration in inflammatory diseases, such as atherosclerosis and rheumatoid arthritis (21, 31) . MCP-1 can induce both the chemotaxis and differentiation of osteoclasts (10, 11, 15) . Very high levels of MCP-1 have been reported in the gingival crevicular fluid of aggressive periodontitis subjects (3). In addition, Pradeep et al. (24) showed that serum MCP-1 levels increased proportionally with the severity of periodontal disease.
Osteoblasts are specialized cells responsible for bone formation in vertebrates. In addition, osteoblasts regulate osteoclastogenesis via several mechanisms (20, 30) . Previous studies have demonstrated that osteoblastic cells secrete MCP-1 in response to inflammatory mediators or periodontal pathogens (6, 9, 15) . However, we have little information about the ability of bacterial flagellin with regard to MCP-1 expression. Therefore, we investigated the effects of flagellin on the expression of MCP-1 in mouse osteoblastic MC3T3-E1 (E1) cells.
MATERIALS AND METHODS
Reagents. Flagellin isolated from Salmonella typhimurium was obtained from Alexis Biochemicals (San Diego, CA). MAP kinase inhibitors-U0126, SP600125 and SB20190-were purchased from Calbiochem (La Jolla, CA).
Cell culture. Osteoblastic E1 cells from mouse calvaria were cultured in α-minimum essential medium (α-MEM; Wako Pure Chemical Industries, Ltd., Osaka, Japan) supplemented with 10% fetal bovine serum (FBS; ICN Biomedicals, Inc., Aurora, OH), L-ascorbic acid 2-phosphate (50 μg/mL; SigmaAldrich, Inc., St Louis, MO), and kanamycin (60 μg/ mL; Meijiseika, Tokyo, Japan). Cultures were maintained at 37°C under a humidified atmosphere with 5% CO 2 in air. After confluence, E1 cells were treated with flagellin with or without various inhibitors.
RT-PCR.
Total RNA from E1 cells was prepared using TRIzol solution (Invitrogen, Carlsbad, CA) according to the manufacturer's protocols. First-strand cDNA was synthesized from total RNA with Rever-As shown in Fig. 1 , TLR5 mRNA was expressed in E1 cells under a non-stimulated condition. It has been reported that various inflammatory mediators induce MCP-1 in osteoblastic cells. Thus, we examined the induction of MCP-1 mRNA expression in E1 cells stimulated by flagellin. Flagellin markedly induced MCP-1 mRNA expression in E1 cells ( Fig. 2A) . Flagellin-induced MCP-1 mRNA expression was transient, and peaked at 1 h. As shown in Fig. 2B , the effect of fagellin on MCP-1 mRNA expression was dose-dependent. The increase in MCP-1 mRNA levels was slightly enhanced at 1 ng/mL flagellin and increased up to 100 ng/mL flagellin.
Effects of flagellin on MCP-1 protein production in mouse E1 cells
To determine whether flagellin induces production of MCP-1 protein by E1 cells, we collected culture media of E1 cells stimulated with flagellin at various times and analyzed MCP-1 concentrations in the supernatant by ELISA. Concomitant with the induction of MCP-1 mRNA expression, the results of ELISA analyses revealed that the release of MCP-1 from E1 cells was significantly increased from 3 to 24 h following the addition of flagellin (Fig. 3) .
Effect of pharmacologic inhibitors on flagellin-induced MCP-1 mRNA in mouse E1 cells
To investigate the involvement of various signaling pathways on the induction of MCP-1 mRNA expression in E1 cells by flagellin, we examined the effect of pharmacologic inhibitors on flagellin-induced MCP-1 mRNA expression. Mouse E1 cells were pretreated with three inhibitors for 1 h at the indicated concentrations prior to flagellin stimulation. Our results indicate that 20 μM U0126, which is a 
DISCUSSION
Periodontal disease is a chronic inflammatory disease that results in gingival inflammation and inflammatory bone destruction of the teeth supporting tissues (22, 23) . Periodontitis results from the pathological interaction of the host immune system with oral bacteria (27) . As a result of this interaction, inflammatory mediators are synthesized locally (1). MCP-1 is a member of the CC chemokine family. Recently, MCP-1 was demonstrated to have the ability to promote osteoclast differentiation and to stimulate osteoclast fusion into multinuclear cells in vitro (10, 11, 15) . Although previous studies have revealed that exposure to lipopolysaccharide induced MCP-1 in osteoblastic cells (9) , there have been no reports on the relationship between flagellin and MCP-1 in osteoblasts. TLR5 recognizes bacterial flagellin (8) . In the present study, we observed that mouse osteoblastic E1 cells constitutively expressed TLR5 mRNA. However, we did not detect flagellin-induced TLR5 mRNA up-regulation (data not shown). Our findings MEK1/2 inhibitor, inhibited the flagellin-induced MCP-1 mRNA expression to almost basal levels. Furthermore, 50 μM SP600125, a JNK inhibitor, significantly suppressed the expression of MCP-1 mRNA. In contrast, SB20190, an inhibitor of p38 MAPK, resulted in only a slight decrease in MCP-1 mRNA induction by flagellin, indicating that the activation of p38 MAPK does not play a significant role in flagellin-induced MCP-1 mRNA expression (Fig. 4A) .
Activation of JNK and MEK-ERK1/2 signaling pathways is required for production of flagellin-induced MCP-1 in mouse osteoblastic cells
We found that JNK and MEK-ERK1/2 signaling pathways are important for flagellin-induced MCP-1 mRNA expression. Therefore, whether flagellininduced MCP-1 release from E1 cells required the activation of MAP kinases was assessed. As shown in Fig. 4B , U0126 and SP600125 markedly diminished the MCP-1 protein production by flagellin, whereas SB20190 did not exhibit any effect. These data are consistent with the results shown in Fig. 4A . (B) E1 cells were pre-treated for 1 h with the following inhibitors: SB20190 (50 μM), SP600125 (50 μM), and U0126 (50 μM). E1 cells were then stimulated with 100 ng/mL flagellin for 6 h. The expression of MCP-1 protein in culture supernatants was measured by ELISA. Data are presented as mean ± S.E. *P < 0.01, compared with control group (flagellin alone).
are generally consistent with those of other investigators, although there are some differences: Madrazo et al. (16) have reported that murine primary osteoblasts constitutively express low levels of TLR5 mRNA, and this expression is up-regulated following exposure to bacteria or to the TLR5 agonist, flagellin. Various chemokines and cytokines have been detected in the gingival fluids and gingival tissue of periodontitis patients (5) . TLRs are also expressed in a variety of non-immune cells, where their function is less well understood. To clarify the consequences of osteoblast recognition of bacterial products, we analyzed mRNA expression changes of osteoblastic cells after stimulation with the TLR5 ligand. Flagellin was chosen as a ligand of TLR5 because it is the main component of bacterial flagella, including that of T. denticola, which is known to be a major causative agent in adult periodontitis (17, 26, 28) . Flagellin induced the expression of two major classes of chemokines, CC and CXC (18, 25) . In our experiments, the mRNA of one of the CC chemokines, MCP-1, was up-regulated by flagellin stimulation in osteoblastic E1 cells. MCP-1 was previously detected in gingival fluids of patients with periodontitis. Hanazawa et al. (7) reported that MCP-1 is involved in macrophage infiltration in periodontal disease. The time course of MCP-1 expression, with an early induction of MCP-1 mRNA within 1 h, suggests that TLR5 signaling directly activates the MCP-1 gene. However, we cannot rule out that MCP-1 secretion following TLR5 stimulation of osteoblasts is dependent on the production of cytokines by the same cells in periodontitis. Nevertheless, our results using in vitro cultures clearly demonstrate that MCP-1 production by osteoblasts is not dependent on the presence of other cells, such as macrophages or monocytes, as a source of stimulating cytokines.
Taken together, we demonstrate that osteoblastic E1 cells produce MCP-1 upon stimulation of TLR5 with agonistic flagellin. Although inflamed gingival tissues have the potential to synthesize chemokines, our findings extend these previous results, demonstrating that stimulated osteoblasts produce an astonishing variety of different chemokines. Cytokines such as IL-1β, derived from infiltrating monocytes or T cells, stimulate gingival fibroblasts to secrete chemokines. However, the expression of MCP-1 in inflamed alveolar bone osteoblasts suggests additional mechanisms of induction. In this study, we propose direct activation of osteoblasts via TLR5, thereby resulting in MCP-1 secretion. Our results support strategies targeting TLR5 signaling pathways to inhibit alveolar bone destruction in periodontitis. In various cells, TLR5 signaling results in the activation of MAPKs (13) . We have investigated these pathways by pretreatment of osteoblast with highly specific inhibitors of MAP kinases (JNK, ERK, and p38). The addition of SP600125 or U0126 reduced the levels of flagellin-induced MCP-1 mRNA expression in a dose-dependent manner. However, there was no change in the flagellin-induced MCP-1 expression following the addition of the SB20190. When SP600125 and U0126 were used, at a concentration that has previously been shown to completely block JNK and ERK activation, respectively, the induction of MCP-1 was also nearly abolished. This indicates that activation of JNK and ERK, but not p38 MAPK, is indispensable for flagellin-induced MCP-1 production in osteoblastic MC3T3-E1 cells. In summary, we examined the effect of the TLR5 ligand, bacterial flagellin, on the expression of the MCP-1 chemokine in mouse osteoblastic MC3T3-E1 cells. The results of this study show that in MC3T3-E1 cells, flagellin significantly induced MCP-1 mRNA and protein production, and that the JNK and MEK-ERK1/2 signaling pathways are involved in MCP-1 induction. As MCP-1 is related to the severity of periodontal diseases (3, 24) , our results indicate that flagellin may play an important role in the progression of periodontal disease. Results of further studies will provide more insight regarding the role of chemokines and their inhibition in the prevention of periodontal disease.
